Background: The full extent of cardiovascular morbidity in inflammatory bowel disease is not well understood. Objective: To comprehensively study the association of different cardiovascular diseases in hospitalized patients with inflammatory bowel disease (IBD) using a large database. Methods: We used the Nationwide Inpatient Sample (NIS) database to perform a crosssectional study. The study group was defined as all hospitalized patients between ages 18-60 years included in the NIS 2006 database with a discharge diagnosis of IBD, as per the International Classification of Diseases -Clinical Modification, 9th revision (ICD-9-CM) codes. Individuals in the same age group whose hospital discharge records did not note IBD were identified as the control group. Cardiovascular diseases, identified by the ICD-9-CM codes, were studied comprehensively for their association with IBD using multivariate logistic regression analysis. Odds ratios were calculated adjusting for relevant patient comorbidities. Results: IBD was found to be strongly associated with mesenteric ischemia (adjusted odds ratio (aOR), 3.4; 95% confidence interval (CI), 2.9-4.0) and venous thrombotic diseases (aOR, 1.38; 95% CI, 1.25-1.53). Age and gender stratified analysis revealed that IBD is positively associated with dysrhythmias in females aged 18-39 years (aOR, 2.05; 95% CI, 1.72-2.44). We did not find an increased risk of other cardiovascular diseases in IBD patients.
Introduction
Chronic systemic inflammation has been shown to be a potential risk factor for several forms of cardiovascular diseases. [1] [2] [3] Persistently increased chronic inflammatory markers in blood such as IL-6, TNF-α, activated Protein C, C-reactive protein have been shown, in various studies, to be strongly associated with premature atherosclerosis, atrial fibrillation, heart block and dilated cardiomyopathy. [4] [5] [6] [7] Inflammatory bowel disease (IBD) is a chronic inflammatory state marked by recurrent exacerbations and periods of remission. While the association of vascular diseases, both arterial and venous, with IBD has been reported in literature, [8] [9] [10] [11] the association of different forms of cardiovascular diseases with IBD has been less well studied. A study by Bernstein et al. 8 showed an increased risk for ischemic heart disease for all IBD patients however a subsequent study by Ha et al. 9 did not show such an association in their overall analysis. Notably, while these large sample studies looked at ischemic cardiovascular diseases, they did not attempt to explore the association of IBD with other forms of cardiovascular disease. A few smaller studies and case reports have documented an increased risk of cardiomyopathy, rhythm and conduction disorders in patients with IBD. [12] [13] [14] [15] [16] Chronic inflammation and alterations in cytokines in IBD have been postulated to be etiologic factors in these associations. We performed a cross-sectional study to comprehensively explore the association between vascular diseases, coronary heart disease as well as other cardiovascular diseases with IBD using the largest nationwide inpatient database in the United States.
Methods
We used the discharge data from the Nationwide Inpatient Sample (NIS) database for the year 2006 for our cross-sectional study. The Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality is the largest all payer inpatient database in the United States. 17 The database contains a 20% stratified sample of all discharges from US non federal short term general hospitals, subspecialty hospitals and public hospitals and is stratified based on the number of beds, ownership, hospital teaching status, US region and state. Stratified random sampling ensures that the database is representative of the US population and accounts for 90% of all hospitalizations in the United States after applying appropriate weights. The NIS includes information on demographic characteristics, hospital characteristics, up to 15 diagnostic and procedure codes based on the International Classification of Diseases 9th revision, Clinical Modification (ICD-9-CM) and outcomes based on patient discharge records. 17 Each record represents a single hospitalization and thus multiple records are possible for an individual with recurrent hospitalizations. NIS data compares favorably with the National Hospital Discharge Survey, supporting the validity of this database. 18 
Study and Control Group Definitions
Our study group consisted of patients hospitalized in 2006 and included in the NIS database, between ages 18-60 years with a diagnosis of either ulcerative colitis (UC) (ICD-9-CM codes: 556.0-556.9) (n = 47710) or Crohn's disease (CD) (ICD-9-CM codes: 555.0-555.9) (n = 102296) in any of 15 available discharge codes for each hospitalization. Inflammatory bowel disease (IBD) (n = 148228) was defined as a patient having either UC or CD (ICD-9-CM 555 and 556). Control group included subjects in the database from 2006 without a diagnosis of IBD, again limited to the age group of 18-60 years.
Outcome Variables and Other Covariates
The primary outcome measures included ischemic heart disease (IHD) (ICD-9-CM 410 to 414), dysrhythmias (ICD-9-CM 427), conduction disturbances (ICD-9-CM 426), cardiomyopathy (ICD-9-CM 425), venous thromboembolic disorders (VTEs) (which include deep vein thrombosis -ICD-9-CM 453.4, 451.1; pulmonary embolism -ICD-9-CM 415.1; portal vein thrombosis -ICD-9-CM 452), peripheral vascular disease (PVD) (ICD-9-CM 440.2, 440.4, 443.9), arterial thromboembolic Disorders (ATEDs) (which include cerebrovascular occlusion -ICD-9-CM 433 to 435 and mesenteric ischemia -ICD-9-CM 557) and their subcategories identified by the specific ICD-9 codes. Dysrhythmias included tachyarrhythmias of ventricular, supraventricular and atrial origins, and other specified and unspecified cardiac dysrhythmias. Conduction disturbances included atrioventricular blocks, bundle branch blocks and other unspecified conduction disorders.
Variables that were considered a potential source of confounding included diagnoses of diabetes mellitus (ICD-9CM 250.x), hypertension (ICD-9CM 401.x), and hyperlipidemia (ICD-9CM 272.4). We adjusted for these variables in the analysis. In a subanalysis for ATEDs, we further adjusted for hypercoagulable states (ICD-9CM 289.81) and hypovolemia (ICD-9CM 276.5) which could be potential confounders for ischemic events. For VTEs, we did a subanalysis adjusting for hypercoagulable states (ICD-9CM 289.81).
Statistical Analysis
All statistical analyses were performed using the survey commands (svy) in Stata MP 10.0 (StataCorp., College Station, TX StataCorp., Stata survey data reference manual release 10, Stata Press, College Station, TX; 2007) to adjust for the complex sampling design of the NIS. 17 Appropriate hospital and discharge level weights published by HCUP were applied to the NIS 2006 data for weighted analysis to reflect nationwide data during the study period. 17 Multivariate logistic regression analysis was used to calculate the adjusted odds ratios (aOR) of the outcomes between the study and the control groups after adjusting for the patient comorbidities which might impact cardiovascular outcomes -hypertension, diabetes and hyperlipidemia. Additional covariates, which might influence certain outcomes, were included in the logistic regression model where applicable and are described in the relevant results section. Association of each outcome variable with UC, CD and IBD was reported as adjusted odds ratios (aOR) with 95% CI. To investigate the effect of gender and age, stratified analyses were performed using the previously defined categories. To adjust for multiple testing, where applicable, a conservative Sidak adjustment was made to reduce the alpha level of 0.05 to 0.004 for a total of 13 independent comparisons. The research protocol was exempted by the institutional review board of University of Washington, Seattle, WA.
Results
A total of 148,229 hospitalizations in the NIS 2006 included a discharge diagnosis of IBD -45,933 had UC, 100,519 had CD and 1777 had both UC and CD recorded in their discharge diagnosis. Table 1 details the demographic characteristics and shows the prevalence of different cardiovascular morbidities (the study outcomes) and patient comorbidities in the studied population. The prevalence of cardiovascular outcomes were all less than 0.1 (b 10%) in both study and control groups. With 9.3% prevalence in the inpatient population, ischemic heart disease was the most common cardiovascular morbidity noted in our study, and it was significantly lower in the IBD group (4.8%, p b 0.001). Table 2 summarizes the association of Ischemic Heart Disease (IHD) in inpatient IBD population. After adjusting for hypertension, diabetes and hyperlipidemia, IBD was found to be inversely associated with ischemic heart disease (aOR 0.60; CI 0.56-0.65). Both UC and CD had lower odds with aOR of 0.56 (CI 0.49-0.63) and 0.62 (CI 0.56-0.68) respectively. Age and gender stratified analyses summarized in Table 3 revealed that, except for young females; this inverse association is maintained across all strata in IBD and also in both UC and CD independently. Young females with IBD, aged 18-39, showed a trend towards increased odds of ischemic heart disease compared to controls; however this association was not statistically significant (see Table 3 ).
Ischemic Heart Disease

Dysrhythmias
In the overall analysis, dysrhythmias showed an inverse association with IBD (aOR 0.81; CI 0. 
Conduction Disorders and Cardiomyopathy
After adjusting for hypertension, diabetes and hyperlipidemia, IBD was again found to be inversely associated with both conduction disorders (aOR 0.66; CI 0.54-0.79) and cardiomyopathy (aOR 0.47; CI 0.40-0.56). This inverse association remained consistent across almost all the age and gender stratified groups in both UC and CD. We noted that younger female patients (aged 18-39), had a trend towards increased odds of conduction disorders when compared to the controls (IBD -aOR 1.39; CI 0.72-2.69; CD -aOR 1.68; CI 0.84-3.4).
Mesenteric Ischemia
A significant association was found between IBD and mesenteric ischemia (aOR 3.4, CI 2.90-4.00) in inpatient population. The odds were higher in both UC (aOR 5.3, CI 4.24-6.74) and CD (aOR 2.58, CI 2.09-3.17) overall and across all the age and gender subcategories in the stratified analyses. Notably, the odds of mesenteric ischemia were higher in UC than in CD for all subcategories. Among the age and gender subcategories, young females in the age group from 18 to 39 yrs had the highest odds of mesenteric ischemia with IBD (aOR 6 
Embolic Strokes
Embolic strokes also showed inverse association with IBD in the overall analysis (aOR 0.47; CI 0.39-0.56), and in most of the age and gender subcategories. Young males with CD (aOR 1.77; CI 0.94-3.35) and young females with UC (aOR 1.52; CI 0.68-3.39) had higher odds of embolic strokes compared to the control group, however, this relationship was not statistically significant (Table 3 ).
Peripheral Vascular Disease
Peripheral vascular disease showed an inverse association with IBD in the overall analysis (aOR 0.57; CI 0.47-0.68) and in most of the age and gender subcategories. Younger females aged 18-39 with CD showed a trend towards higher odds of PVD when compared to the controls (aOR 1.18; CI 0.35-4.02), however this relationship was not statistically significant.
Venous Thromboembolic Disorders
Odds of VTEs were higher in patients with IBD (aOR 1.38; CI 1.25-1.53), UC (aOR 1.79; CI 1.52-2.11) and CD (aOR 1.17; CI 1.04-1.31) compared to other inpatients when adjusted for hyperlipidemia, hypertension and diabetes. Among age and gender subcategories, the odds were most pronounced among young female inpatients (aged 18-39 yrs) with UC (aOR 3.16; CI 2.19-4.58). It was interesting to note that the higher odds persisted even after adjusting for hypercoagulable disorders.
A subanalysis revealed increased odds of portal vein thrombosis (PVT) in IBD patients (aOR 1.7; CI 1.01-2.8), which persisted after adjusting for hypercoagulable disorders. Age and gender stratified analysis revealed that the younger age group (18-39 years) had the highest odds of PVT in IBD when compared to the controls (aOR 4.1; CI 1.87-8.9) and higher so, in females (aOR 10.9; CI 4.62-25.7). 
Discussion
Inflammatory bowel disease is a chronic systemic disease with varying degrees of involvement outside the bowel. Though the exact pathogenesis of the different systemic manifestations of IBD is not clearly understood, various inflammatory mediators and cytokines are thought to play a role. [19] [20] [21] [22] [23] Many of these cytokines have also been implicated in the pathogenesis of various cardiovascular diseases 2, 4, 6, 7, [24] [25] [26] and as a result, chronic inflammatory diseases which in-turn lead to high serum concentrations of these cytokines, have been demonstrated to be associated with significant cardiovascular morbidity. 5, 7, 27, 28 Thus, we hypothesized that IBD might also be associated with different cardiovascular diseases which might either reflect a common pathogenic mechanism or a cause-effect relationship. Our large dataset is well suited to explore such an epidemiological association. 29 Few studies have previously looked at association of ischemic heart disease with IBD. One small patient group study indirectly looking at cardiovascular risk through Framingham scores in IBD patients, suggested an increased risk of ischemic heart disease with IBD. 30 However the relatively small sample size of this study was a significant limitation impacting conclusions drawn through such an indirect methodology. A larger sample studied by Bernstein et al. 8 used the 'University of Manitoba IBD epidemiology database' and demonstrated an increased risk of ischemic heart disease in all IBD patients, however a subsequent study by Ha et al. 9 using the 'Thomson Reuters MarketScan Research claims database' did not show such an association in their overall analysis. Their subgroup analysis, though, revealed an increased risk of myocardial infarction in women over the age of 40 years with IBD. Our study used a much larger database than either of the two aforementioned studies, and showed an inverse association of IBD with IHD in hospitalized patients, a result which was paradoxical to our hypothesis. This inverse association was consistent and statistically significant in both UC and CD, across most age and gender subcategories.
One of the many possible explanations for this interesting finding may be the protective role of chronic salicylate use in this patient group as part of their therapy. Salicylic acid, which is the main active moiety of Aspirin (acetyl salicylic acid) is also the main active moiety of 5-ASA (amino salicylic acid), sulfasalazine and mesalamine, the drugs commonly used for chronic outpatient management of IBD. Salicylic acid has been shown to inhibit leukocyte chemotaxis and production of chemotactic eicosanoids and interleukin-8.
31,32 5-ASA has also been shown to induce apoptosis and is an inducer and agonist of peroxisome proliferator-activated receptors and an inhibitor of nuclear factor, all of which result in suppression of inflammation. 33 These anti-inflammatory and anti-oxidant properties of salicylic acid may suggest a cardio-protective effect of 5-ASA, when used long-term.
Also, it has been documented previously that in IBD patients, malnutrition due to chronic diarrhea and impaired eating behavior leads to a lower body mass index (BMI) and low body fat, 34, 35 thus indirectly lowering IHD risk. A few studies have reported that IBD patients are in general non smokers, 36 which again could lower IHD risk. Although smoking has been shown to be implicated as a risk factor for developing CD and worsens its outcome, the prevalence of smoking in CD has been highly variable in studies. In a recent study from UK, the prevalence of current smoking in patients with CD was 20% and was lower than that of the general UK population of 22%. 37 This number is much lower than those reported in prior studies with a range of 26-49%. 37 Increased awareness about the adverse effects of smoking on CD may have been the cause of the decrease in the prevalence of smoking in CD. However, we could not adjust for the effect of smoking and BMI on the ischemic heart disease in our database. Also, decreased IHD outcomes might have been observed due to the fact that most IBD patients enter the healthcare system at a younger age, are regularly followed by their physicians, and are subject to regular monitoring and screening for the risk factors for IHD.
One important consideration, however, is that since this is a hospital based data sample, false negative associations or inverse associations could be direct result of Berkson's bias. This bias first described by Berkson in 1946, arises as a mathematical phenomenon in case-control studies based solely on hospitalized patients and is a form of selection bias causing the hospital cases and controls to be systematically different from each other. 38 This bias is difficult to adjust for using statistical methods.
We also looked into the association of dysrhythmias with IBD. Dysrhythmias included all rhythm disorders of the heartmost notably tachycardias of atrial, supraventricular, nodal, infranodal and ventricular origin. While overall analysis showed an inverse association between dysrhythmias and IBD, stratified analysis revealed that dysrhythmias were found to be positively associated with IBD in females, more so in the younger age group (aged 18-39) and in UC. Previous studies have shown an association of different types of cardiac dysrhythmias with other chronic systemic inflammatory conditions. [39] [40] [41] These associations are thought to result either from the original inflammatory condition adversely impacting the conduction system of the heart, or from the secondary effects of the inflammatory markers like CRP on the conduction system. Also, other factors during the active phase of the disease such as increased cytokine levels, hospitalization, use of steroids and antidiarrheals, and infection may contribute by affecting autonomic function leading to an increase in the risk for dysrhythmias. A recent study reported that UC patients have an increased sympathetic Autonomic Nervous System activity independent of symptom severity. 42 Patients with UC seem to have a lower parasympathetic tone compared to CD and the general population 43 which can further accentuate tachyarrhythmic phenomena.
Conduction disorders resulting from impairment of the normal conduction system of the heart, mainly the bradyarrhythmias again showed an inverse association with IBD and its subcategories in our study. Autonomic dysfunction in IBD patients and lower parasympathetic function could contribute to this inverse relationship with bradyarrhythmias. 42 Cardiomyopathy also showed a similar inverse association which was consistent among all the categories. The majority of cases of cardiomyopathy in the US population are due to ischemic heart disease, 44 and thus, this inverse association to cardiomyopathy could result from the inverse association to ischemic heart disease, as described earlier.
Previous studies have explored the association between VTE and IBD. 11, 45, 46 Our results were consistent with these findings. It was also interesting to find a strong association between IBD and arterial thrombotic events like mesenteric ischemia, consistent with recent population based studies which have shown such an association. 9 Given that our study population consisted of only hospitalized IBD patients and that they might be in an acute flare, our results seem to be more pronounced than population based studies. One could argue that an ascertainment bias could act in favor of the IBD group, as IBD patients were more likely to have been subjected to imaging procedures required to make the diagnosis. It is unlikely that a significant ascertainment bias occurred in our study. Our dataset included only inpatients, the intensity of medical care and clinical suspicion for an embolic event in both cases and controls could safely be assumed to be the same irrespective of their IBD status. Furthermore, one could argue that the increase in the occurrence of mesenteric ischemia could be attributed to higher prevalence of other risk factors such as hypovolemia, myocardial ischemia or hypercoagulable states. However the increased risk for mesenteric ischemia persisted even after adjusting for these risk factors in our logistic regression model. Further studies are warranted to look at the role played by medications, disease severity, a risk scoring system and a role of prophylactic anti-coagulation in hospitalized IBD patients.
It was interesting to note that young females aged 18-39 years with IBD showed a trend towards increased odds of certain cardiovascular diseases when compared to the controls, though the association was not statistically significant. Young females with CD showed a trend towards increased odds of conduction disorders and peripheral artery disease, while young females with UC showed a trend towards increased odds of embolic strokes. While the increased risk of embolic strokes in this age-group could be contributed by oral contraceptive usage, the increased risk of other cardiovascular diseases in this category is difficult to explain, and warrants further investigation.
There are a number of limitations in our study. Our study was a cross-sectional study, and this makes it impossible to explore causality. The study included only hospitalized patients and has limitations in extrapolation to the outpatient population. Also, studies based on solely hospitalized patients are subject to certain biases which might lead to false negative associations and these biases are difficult to adjust statistically.
However, the strength of our study was the large sample size. The dataset represented the largest known crosssectional study to explore the occurrence of various cardiovascular diseases among hospitalized IBD patients. Also, the sampling design was such that the database represented the US population and accounted for 90% of all the hospitalizations. The dataset has been shown to be highly generalizable to US inpatients and thus, was well suited for exploration of such epidemiological associations. 29 The second important strength of the study was that we did a comprehensive exploration of different cardiovascular diseases in IBD patients. To our knowledge, there has not been a study to date which has looked at the broad spectrum of cardiovascular diseases among IBD patients. Our study was designed to be hypothesis generating for future cohort studies.
In conclusion, our study of hospitalized patients added evidence to the theory that, patients with IBD are at an increased risk for VTEs and mesenteric ischemia. Our analysis suggested that among hospitalized patients, UC poses a higher risk compared to CD for mesenteric ischemia and VTEs. However, contrary to what has been suggested in the existing literature, our study suggested that hospitalized patients with IBD might actually be at a lower risk for myocardial ischemia, cardiomyopathy, conduction disorders and embolic strokes compared to hospitalized patients without IBD. Our study also suggested that younger female hospitalized patients with IBD might be at increased risk for dysrhythmias. Further studies are needed to identify the cause for these observed associations and to explore whether or not this association persists even in the remission phase of the disease.
